Matches in Nanopublications for { ?s ?p "[The crystal structure, of Pro252Arg FGFR1c in complex with FGF2, demonstrates that the enhanced ligand binding is due to an additional set of receptor-ligand hydrogen bonds, similar to those gain-of-function interactions that occur in the Apert syndrome Pro253Arg FGFR2c-FGF2 crystal structure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[The crystal structure, of Pro252Arg FGFR1c in complex with FGF2, demonstrates that the enhanced ligand binding is due to an additional set of receptor-ligand hydrogen bonds, similar to those gain-of-function interactions that occur in the Apert syndrome Pro253Arg FGFR2c-FGF2 crystal structure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP398277.RAY-o5pQRXuISofdbLW6-Ro5szpScZonVGmTDnFDSjMYM130_assertion description "[The crystal structure, of Pro252Arg FGFR1c in complex with FGF2, demonstrates that the enhanced ligand binding is due to an additional set of receptor-ligand hydrogen bonds, similar to those gain-of-function interactions that occur in the Apert syndrome Pro253Arg FGFR2c-FGF2 crystal structure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP398277.RAY-o5pQRXuISofdbLW6-Ro5szpScZonVGmTDnFDSjMYM130_provenance.
- NP399862.RAC4qxOCHeZ5jmmQUifTGU_vXkVIRGLfAv5o5fDwoMZPM130_assertion description "[The crystal structure, of Pro252Arg FGFR1c in complex with FGF2, demonstrates that the enhanced ligand binding is due to an additional set of receptor-ligand hydrogen bonds, similar to those gain-of-function interactions that occur in the Apert syndrome Pro253Arg FGFR2c-FGF2 crystal structure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP399862.RAC4qxOCHeZ5jmmQUifTGU_vXkVIRGLfAv5o5fDwoMZPM130_provenance.
- NP420431.RAtaw60crYC1H9DClDKAl6Aoa70vYBpXe0iHbMUCuno-M130_assertion description "[The crystal structure, of Pro252Arg FGFR1c in complex with FGF2, demonstrates that the enhanced ligand binding is due to an additional set of receptor-ligand hydrogen bonds, similar to those gain-of-function interactions that occur in the Apert syndrome Pro253Arg FGFR2c-FGF2 crystal structure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420431.RAtaw60crYC1H9DClDKAl6Aoa70vYBpXe0iHbMUCuno-M130_provenance.
- NP420424.RAz4afXnAXZ5ip3vS6HXrzmLivjMYdvwa8t_fCWx3UDnY130_assertion description "[The crystal structure, of Pro252Arg FGFR1c in complex with FGF2, demonstrates that the enhanced ligand binding is due to an additional set of receptor-ligand hydrogen bonds, similar to those gain-of-function interactions that occur in the Apert syndrome Pro253Arg FGFR2c-FGF2 crystal structure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420424.RAz4afXnAXZ5ip3vS6HXrzmLivjMYdvwa8t_fCWx3UDnY130_provenance.